378 related articles for article (PubMed ID: 27649286)
1. Effectiveness and cost-effectiveness of interventions that cause weight loss and reduce the risk of cardiovascular disease.
Zomer E; Leach R; Trimmer C; Lobstein T; Morris S; James WP; Finer N
Diabetes Obes Metab; 2017 Jan; 19(1):118-124. PubMed ID: 27649286
[TBL] [Abstract][Full Text] [Related]
2. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
Kang HY; Ko SK; Liew D
Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
[TBL] [Abstract][Full Text] [Related]
3. Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea.
Liew D; Park HJ; Ko SK
Clin Ther; 2009 Oct; 31(10):2189-203; discussion 2150-1. PubMed ID: 19922890
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of a cardiovascular disease primary prevention programme in a primary health care setting. Results of the Polish part of the EUROACTION project.
Sović N; Pająk A; Jankowski P; Duenas A; Kawecka-Jaszcz K; Wolfshaut-Wolak R; Stepaniak U; Kawalec P
Kardiol Pol; 2013; 71(7):702-11. PubMed ID: 23907903
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of medical primary prevention strategies to reduce absolute risk of cardiovascular disease in Tanzania: a Markov modelling study.
Ngalesoni FN; Ruhago GM; Mori AT; Robberstad B; Norheim OF
BMC Health Serv Res; 2016 May; 16():185. PubMed ID: 27184802
[TBL] [Abstract][Full Text] [Related]
6. Incremental cost-effectiveness of evidence-based non-surgical weight loss strategies.
Finkelstein EA; Verghese NR
Clin Obes; 2019 Apr; 9(2):e12294. PubMed ID: 30677252
[TBL] [Abstract][Full Text] [Related]
7. The cost-effectiveness of canakinumab for secondary prevention of cardiovascular disease: The Australian healthcare perspective.
Zomer E; Liew D; Tonkin A; Trauer JM; Ademi Z
Int J Cardiol; 2019 Jun; 285():1-5. PubMed ID: 30686493
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of a community-based cardiovascular disease prevention intervention in medically underserved rural areas.
Wang H; Kenkel D; Graham ML; Paul LC; Folta SC; Nelson ME; Strogatz D; Seguin RA
BMC Health Serv Res; 2019 May; 19(1):315. PubMed ID: 31096977
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of the Modified Atherogenic Index of Plasma during Body Mass Reduction in Polish Obese/Overweight People.
Zalejska-Fiolka J; Hubková B; Birková A; Veliká B; Puchalska B; Kasperczyk S; Błaszczyk U; Fiolka R; Bożek A; Maksym B; Mareková M; Birkner E
Int J Environ Res Public Health; 2018 Dec; 16(1):. PubMed ID: 30591697
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of diet and exercise interventions to reduce overweight and obesity.
Forster M; Veerman JL; Barendregt JJ; Vos T
Int J Obes (Lond); 2011 Aug; 35(8):1071-8. PubMed ID: 21224825
[TBL] [Abstract][Full Text] [Related]
11. The impact of prevention on reducing the burden of cardiovascular disease.
Kahn R; Robertson RM; Smith R; Eddy D
Circulation; 2008 Jul; 118(5):576-85. PubMed ID: 18606915
[TBL] [Abstract][Full Text] [Related]
12. A health economic model to assess the cost-effectiveness of OPTIFAST for the treatment of obesity in the United States.
Nuijten M; Marczewska A; Araujo Torres K; Rasouli B; Perugini M
J Med Econ; 2018 Sep; 21(9):835-844. PubMed ID: 29678127
[TBL] [Abstract][Full Text] [Related]
13. The cost-effectiveness of primary care referral to a UK commercial weight loss programme.
Meads DM; Hulme CT; Hall P; Hill AJ
Clin Obes; 2014 Dec; 4(6):324-32. PubMed ID: 25826162
[TBL] [Abstract][Full Text] [Related]
14. Economic evaluations of adult weight management interventions: a systematic literature review focusing on methods used for determining health impacts.
Griffiths UK; Anigbogu B; Nanchahal K
Appl Health Econ Health Policy; 2012 May; 10(3):145-62. PubMed ID: 22439628
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of a community-based weight control intervention targeting a low-socioeconomic-status Mexican-origin population.
Wilson KJ; Brown HS; Bastida E
Health Promot Pract; 2015 Jan; 16(1):101-8. PubMed ID: 24893680
[TBL] [Abstract][Full Text] [Related]
16. The effectiveness and cost-effectiveness of plant sterol or stanol-enriched functional foods as a primary prevention strategy for people with cardiovascular disease risk in England: a modeling study.
Yang W; Gage H; Jackson D; Raats M
Eur J Health Econ; 2018 Sep; 19(7):909-922. PubMed ID: 29110223
[TBL] [Abstract][Full Text] [Related]
17. The Population Cost-Effectiveness of Weight Watchers with General Practitioner Referral Compared with Standard Care.
Lymer S; Schofield D; Cunich M; Lee CMY; Fuller N; Caterson I; Colagiuri S
Obesity (Silver Spring); 2018 Aug; 26(8):1261-1269. PubMed ID: 30138545
[TBL] [Abstract][Full Text] [Related]
18. [Effectiveness of different screening strategies for primary prevention of cardiovascular diseases in a rural northern Chinese population].
Si YQ; Tang X; Zhang DD; He L; Cao Y; Wang JW; Li N; Liu JJ; Gao P; Hu YH
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Jun; 50(3):443-449. PubMed ID: 29930411
[TBL] [Abstract][Full Text] [Related]
19. Cost effectiveness of primary care referral to a commercial provider for weight loss treatment, relative to standard care: a modelled lifetime analysis.
Fuller NR; Carter H; Schofield D; Hauner H; Jebb SA; Colagiuri S; Caterson ID
Int J Obes (Lond); 2014 Aug; 38(8):1104-9. PubMed ID: 24301133
[TBL] [Abstract][Full Text] [Related]
20. Economic evaluation of telephone-based weight loss support for patients with knee osteoarthritis: a randomised controlled trial.
O'Brien KM; van Dongen JM; Williams A; Kamper SJ; Wiggers J; Hodder RK; Campbell E; Robson EK; Haskins R; Rissel C; Williams CM
BMC Public Health; 2018 Dec; 18(1):1408. PubMed ID: 30587191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
